These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12639208)

  • 1. Thrombocytopenia associated with levodopa treatment.
    Giner V; Rueda D; Salvador A; Hernández JC; Esteban MJ; Redón J
    Arch Intern Med; 2003 Mar; 163(6):735-6. PubMed ID: 12639208
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Nutt JG
    Neurology; 2006 May; 66(10):1611-2; author reply 1611-2. PubMed ID: 16717244
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Deleu D; Hanssens Y
    Neurology; 2006 May; 66(10):1611-2; author reply 1611-2. PubMed ID: 16721952
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Nyholm D; Jansson R; Willows T; Remahl IN
    Neurology; 2005 Nov; 65(9):1506-7. PubMed ID: 16275852
    [No Abstract]   [Full Text] [Related]  

  • 5. New use for an old drug: amantadine benefits levodopa-induced dyskinesia.
    Rajput AH; Rajput A; Lang AE; Kumar R; Uitti RJ; Galvez-Jimenez N
    Mov Disord; 1998 Sep; 13(5):851. PubMed ID: 9756161
    [No Abstract]   [Full Text] [Related]  

  • 6. [L-dopa effectiveness decreases over time. What helps Parkinson patients stay mobile?].
    Wedekind S
    MMW Fortschr Med; 2005 Jun; 147(22):10. PubMed ID: 15977622
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problem in prolonged levodopa administration of Parkinson disease patients--from the standpoint of the autonomic nervous function].
    Matsui TA; Nishikawa S; Saigo K; Kihara M; Takahashi M
    Rinsho Shinkeigaku; 1998 Apr; 38(4):295-300. PubMed ID: 9742874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current strategies in the drug treatment of advanced Parkinson's disease--new modes of dopamine substitution.
    Schelosky L; Poewe W
    Acta Neurol Scand Suppl; 1993; 146():46-9. PubMed ID: 8101415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies with levodopa/carbidopa intestinal gel].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2014 Jan; 67(1-2):5-8. PubMed ID: 24654442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroconvulsive therapy in drug-induced psychiatric states and neuroleptic malignant syndrome.
    Ozer F; Meral H; Aydin B; Hanoglu L; Aydemir T; Oral T
    J ECT; 2005 Jun; 21(2):125-7. PubMed ID: 15905757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
    Rascol O; Brefel-Courbon C; Descombes S; Montastruc JL
    Adv Neurol; 1999; 80():485-90. PubMed ID: 10410760
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyponatraemia and dopaminergic agents.
    Larner AJ
    Postgrad Med J; 1994 Apr; 70(822):310-1. PubMed ID: 7910397
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in Parkinson's disease.
    Vécsei L
    Ideggyogy Sz; 2002 Nov; 55(11-12):406-7. PubMed ID: 12632802
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa addiction in non-parkinsonian patients.
    Steiner I; Wirguin I
    Neurology; 2003 Nov; 61(10):1451. PubMed ID: 14638980
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dopaminomimetic psychosis].
    Ilić T; Marić D; Ivanisević V; Magdić B
    Vojnosanit Pregl; 1995; 52(2):184-8. PubMed ID: 7571535
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategies in the treatment of early Parkinson's disease.
    Rinne UK
    Acta Neurol Scand Suppl; 1993; 146():50-3. PubMed ID: 8101417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyponatraemia due to amantadine hydrochloride and L-dopa/carbidopa.
    Lammers GJ; Roos RA
    Lancet; 1993 Aug; 342(8868):439. PubMed ID: 8101938
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
    Avanzi M; Uber E; Bonfà F
    Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    Mov Disord; 1998 Sep; 13(5):798-802. PubMed ID: 9756148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulating debate in the field of addiction.
    Carter A; Hall W; Ambermoon P; Dissanayaka N; O'Sullivan J
    Addiction; 2012 Feb; 107(2):253. PubMed ID: 22248135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.